ADMA Biologics Inc (ADMA)
9.215
+0.16
(+1.71%)
USD |
NASDAQ |
May 17, 16:00
9.21
0.00 (0.00%)
After-Hours: 20:00
ADMA Biologics Price to Book Value: 13.89 for May 17, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 17, 2024 | 13.89 |
| May 16, 2024 | 13.66 |
| May 15, 2024 | 13.72 |
| May 14, 2024 | 13.81 |
| May 13, 2024 | 13.26 |
| May 10, 2024 | 13.29 |
| May 09, 2024 | 10.45 |
| May 08, 2024 | 10.35 |
| May 07, 2024 | 10.42 |
| May 06, 2024 | 10.42 |
| May 03, 2024 | 10.27 |
| May 02, 2024 | 10.16 |
| May 01, 2024 | 10.06 |
| April 30, 2024 | 9.831 |
| April 29, 2024 | 9.922 |
| April 26, 2024 | 9.877 |
| April 25, 2024 | 9.711 |
| April 24, 2024 | 9.741 |
| April 23, 2024 | 9.862 |
| April 22, 2024 | 9.349 |
| April 19, 2024 | 9.454 |
| April 18, 2024 | 9.349 |
| April 17, 2024 | 9.108 |
| April 16, 2024 | 9.289 |
| April 15, 2024 | 9.017 |
| Date | Value |
|---|---|
| April 12, 2024 | 9.078 |
| April 11, 2024 | 9.379 |
| April 10, 2024 | 9.108 |
| April 09, 2024 | 9.213 |
| April 08, 2024 | 9.379 |
| April 05, 2024 | 9.635 |
| April 04, 2024 | 9.470 |
| April 03, 2024 | 9.575 |
| April 02, 2024 | 9.711 |
| April 01, 2024 | 9.862 |
| March 31, 2024 | |
| March 28, 2024 | 11.14 |
| March 27, 2024 | 11.38 |
| March 26, 2024 | 10.97 |
| March 25, 2024 | 10.79 |
| March 22, 2024 | 10.62 |
| March 21, 2024 | 10.45 |
| March 20, 2024 | 10.67 |
| March 19, 2024 | 10.45 |
| March 18, 2024 | 10.03 |
| March 15, 2024 | 10.11 |
| March 14, 2024 | 10.16 |
| March 13, 2024 | 10.57 |
| March 12, 2024 | 10.50 |
| March 11, 2024 | 10.43 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.344
Minimum
Sep 29 2021
27.77
Maximum
May 22 2019
5.110
Average
4.54
Median
Jul 05 2019
Price to Book Value Benchmarks
| Vanda Pharmaceuticals Inc | 0.5863 |
| ANI Pharmaceuticals Inc | 2.849 |
| Ligand Pharmaceuticals Inc | 1.917 |
| Johnson & Johnson | 5.315 |
| Puma Biotechnology Inc | 3.875 |
Price to Book Value Related Metrics
| PS Ratio | 7.402 |
| Price to Free Cash Flow | 131.77 |
| Price | 9.215 |
| Earnings Yield | -0.22% |
| Market Cap | 2.135B |
| Operating PE Ratio | 47.35 |
| Normalized PE Ratio | 96.12 |